News 
On December 7th, The Carlyle Group announced that it had reached an agreement to acquire the Acrotec Group, in partnership with its management team, from Castik Capital.
The transaction is subject to regulatory approval and is expected to be completed in the first quarter of 2021.
The Carlyle Group will support Acrotec in accelerating its growth plan through the development of its existing platform and through acquisitions. Leveraging Carlyle’s global Healthcare expertise and network, the partnership will seek to broaden Acrotec’s MedTech business with expansion into new services and geographical areas in Europe and in the United States.
François Billig, founder and CEO of the Acrotec Group, said: “In Carlyle, I am delighted that we have found a partner that understands and appreciates the core values of the Group. This partnership, which represents an important milestone in Acrotec’s history, will significantly accelerate our growth and diversification plan while remaining loyal to our core business in high precision applications. Castik has been a valuable partner over the past four years, supporting the business to consolidate its leading position in mechanical watch making, and overseeing a key phase of its development, while respecting the values of the Group.”
Equity for the investment will be provided by Carlyle Europe Partners (CEP) V, a €6.4bn fund investing in European upper mid-market opportunities across a range of sectors and industries. The transaction follows the announcement in October 2020 that Carlyle has agreed to acquire Flender, a market leader in mechanical and electrical drive technology, in a carve out from Siemens. The Carlyle Group has a long-term global focus on both Industrials and Healthcare, having deployed over $35 billion in aggregate in these sectors since inception. Further details of the transaction were not disclosed.
January 14, 2021